Lexaria Bioscience Corp.
NASDAQ:LEXX
1.08 (USD) • At close May 9, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 0.464 | 0.226 | 0.255 | 0.723 | 0.385 | 0.223 | 0.433 | 0.064 | 0.041 | 0.015 | 1.097 | 1.358 | 1.134 | 0.362 | 0.422 | 0.901 | 0.253 | 0.02 | 0.02 |
| Kosten van de omzet
| 0.005 | 0.032 | 0.072 | 0.175 | 0.099 | 0.023 | 0.025 | 0.03 | 0.046 | 0.03 | 0.795 | 0.783 | 0.668 | 0.274 | 0.548 | 0.913 | 0.125 | 0.093 | 0.093 |
| Brutowinst
| 0.459 | 0.195 | 0.184 | 0.547 | 0.285 | 0.2 | 0.408 | 0.034 | -0.005 | -0.015 | 0.302 | 0.574 | 0.466 | 0.089 | -0.126 | -0.012 | 0.128 | -0.073 | -0.073 |
| Brutowinstmarge
| 0.99 | 0.861 | 0.719 | 0.757 | 0.742 | 0.897 | 0.942 | 0.533 | -0.12 | -1.033 | 0.275 | 0.423 | 0.411 | 0.245 | -0.299 | -0.013 | 0.507 | -3.595 | -3.595 |
| Onderzoek- en ontwikkelingskosten
| 2.361 | 3.667 | 1.843 | 1.263 | 0.387 | 0.556 | 0.493 | 0.054 | 0.009 | 0.146 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 3.852 | 3.062 | 5.725 | 4.971 | 3.569 | 3.128 | 6.024 | 1.633 | 1.012 | 1.486 | 1.273 | 0.562 | 0.678 | 0.467 | 0.458 | 0.475 | 1.01 | 0.121 | 0 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0.204 | 0.515 | 0.489 | 0.209 | 0.185 | 0.277 | 0.008 | 0.003 | 0.041 | 0.001 | 0.001 | 0.004 | 0.02 | 0.02 | 0 |
| Verkoop-, algemene en administratieve kosten
| 3.852 | 3.062 | 5.725 | 4.971 | 3.774 | 3.643 | 6.513 | 1.842 | 1.197 | 1.763 | 0.008 | 0.565 | 0.719 | 0.467 | 0.459 | 0.479 | 1.03 | 0.142 | 0.035 |
| Overige kosten
| 0 | 0 | 0 | 0 | 0.113 | 0.061 | 0.002 | -0.001 | 0.005 | -0.023 | 0 | 0.014 | 0.006 | 0 | 0.008 | 0.001 | 0.148 | -0.003 | 0 |
| Bedrijfskosten
| 6.213 | 6.729 | 7.567 | 6.234 | 4.273 | 4.26 | 7.008 | 1.895 | 1.211 | 1.913 | 0.008 | 0.579 | 0.725 | 0.474 | 0.467 | 0.481 | 1.178 | 0.139 | 0.035 |
| Bedrijfsresultaat
| -5.753 | -6.534 | -7.384 | -5.687 | -3.892 | -3.961 | -6.6 | -1.861 | -1.216 | -1.928 | 0.294 | -0.005 | -0.26 | -0.552 | -0.754 | -0.898 | -1.05 | -0.49 | -0.035 |
| Bedrijfsresultaat ratio
| -12.392 | -28.885 | -28.91 | -7.868 | -10.121 | -17.794 | -15.233 | -29.247 | -29.854 | -131.153 | 0.268 | -0.004 | -0.229 | -1.524 | -1.786 | -0.997 | -4.148 | -24.113 | -1.73 |
| Totaal overige inkomsten en kosten netto
| -0.056 | -0.179 | -0.765 | 1.523 | 0 | -0.228 | -0.009 | -0.006 | -0.035 | -0.055 | -0.355 | -0.247 | -0.276 | -0.279 | 0 | 0.007 | -0.073 | -0.565 | -0.473 |
| Inkomen voor belasting
| -5.809 | -6.713 | -7.384 | -4.164 | -4.085 | -4.158 | -6.609 | -1.929 | -1.277 | -1.983 | -1.871 | -0.252 | -0.538 | -0.552 | -0.754 | -0.971 | -1.055 | -0.212 | -0.076 |
| Inkomen voor belasting ratio
| -12.511 | -29.674 | -28.91 | -5.762 | -10.622 | -18.68 | -15.254 | -30.319 | -31.368 | -134.898 | -1.705 | -0.185 | -0.475 | -1.524 | -1.786 | -1.078 | -4.167 | -10.417 | -3.722 |
| Belastingkosten
| 0 | 0 | -0.114 | -1.66 | -0.054 | 0.04 | -0.009 | -0.054 | -0.06 | -0.181 | 0.294 | 0.247 | 0.279 | 0.167 | -0 | 0.007 | 0.001 | 0.575 | 0.041 |
| Nettowinst
| -5.795 | -6.665 | -7.269 | -2.504 | -4.03 | -4.198 | -6.599 | -1.869 | -1.215 | -1.771 | -1.871 | -0.252 | -0.538 | -0.552 | -0.754 | -0.978 | -1.056 | -0.508 | -0.076 |
| Nettowinstmarge
| -12.482 | -29.464 | -28.463 | -3.465 | -10.481 | -18.858 | -15.23 | -29.373 | -29.834 | -120.426 | -1.705 | -0.185 | -0.475 | -1.524 | -1.786 | -1.086 | -4.171 | -25.029 | -3.729 |
| WPA (Winst Per Aandeel)
| -0.47 | -1.01 | -1.24 | -0.57 | -1.45 | -1.62 | -2.79 | -0.95 | -0.83 | -1.34 | -0.073 | -0.42 | -1.09 | -1.22 | -2.8 | -4.46 | -5.21 | -3.16 | -0.014 |
| Verwaterde WPA
| -0.47 | -1.01 | -1.24 | -0.57 | -1.45 | -1.62 | -2.79 | -0.95 | -0.83 | -1.34 | -0.073 | -0.42 | -1.09 | -1.22 | -2.8 | -4.46 | -5.21 | -3.16 | -0.014 |
| EBITDA
| -5.677 | -6.389 | -6.516 | -5.575 | -4.003 | -4.098 | -6.607 | -1.922 | -1.259 | -1.951 | 0.294 | -0.035 | 0.443 | 0.111 | -0.236 | -0.244 | -0.414 | -0.891 | -0.13 |
| EBITDA ratio
| -12.228 | -28.242 | -25.514 | -7.714 | -10.409 | -18.408 | -15.248 | -30.201 | -30.92 | -132.695 | 0.268 | -0.026 | 0.39 | 0.307 | -0.56 | -0.271 | -1.637 | -43.878 | -6.391 |